These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recurrent Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692 [TBL] [Abstract][Full Text] [Related]
3. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation. Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106 [TBL] [Abstract][Full Text] [Related]
4. RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia. Lee DS; Lee YS; Kim YR; Han KS; Park KU; She CJ; Kim EC; Park SY; Cho HI Cancer Genet Cytogenet; 2002 Dec; 139(2):104-8. PubMed ID: 12550769 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA. Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799 [TBL] [Abstract][Full Text] [Related]
6. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies. Ablain J; Leiva M; Peres L; Fonsart J; Anthony E; de Thé H J Exp Med; 2013 Apr; 210(4):647-53. PubMed ID: 23509325 [TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia. Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384 [TBL] [Abstract][Full Text] [Related]
8. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Sainty D; Liso V; Cantù-Rajnoldi A; Head D; Mozziconacci MJ; Arnoulet C; Benattar L; Fenu S; Mancini M; Duchayne E; Mahon FX; Gutierrez N; Birg F; Biondi A; Grimwade D; Lafage-Pochitaloff M; Hagemeijer A; Flandrin G; ; ; ; Blood; 2000 Aug; 96(4):1287-96. PubMed ID: 10942370 [TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor function of Gata2 in acute promyelocytic leukemia. Katerndahl CDS; Rogers ORS; Day RB; Cai MA; Rooney TP; Helton NM; Hoock M; Ramakrishnan SM; Nonavinkere Srivatsan S; Wartman LD; Miller CA; Ley TJ Blood; 2021 Sep; 138(13):1148-1161. PubMed ID: 34125173 [TBL] [Abstract][Full Text] [Related]
10. Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Hiorns LR; Min T; Swansbury GJ; Zelent A; Dyer MJ; Catovsky D Blood; 1994 May; 83(10):2946-51. PubMed ID: 8180390 [TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes. Lafage-Pochitaloff M; Alcalay M; Brunel V; Longo L; Sainty D; Simonetti J; Birg F; Pelicci PG Blood; 1995 Mar; 85(5):1169-74. PubMed ID: 7858248 [TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts. Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780 [TBL] [Abstract][Full Text] [Related]
14. Absence of natural intracellular retinoids in mouse bone marrow cells and implications for PML-RARA transformation. Niu H; Chacko J; Hadwiger G; Welch JS Blood Cancer J; 2015 Feb; 5(2):e284. PubMed ID: 25723855 [No Abstract] [Full Text] [Related]
15. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology. Zhu G Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. Yin CC; Jain N; Mehrotra M; Zhagn J; Protopopov A; Zuo Z; Pemmaraju N; DiNardo C; Hirsch-Ginsberg C; Wang SA; Medeiros LJ; Chin L; Patel KP; Ravandi F; Futreal A; Bueso-Ramos CE J Natl Compr Canc Netw; 2015 Jan; 13(1):19-22. PubMed ID: 25583766 [TBL] [Abstract][Full Text] [Related]
17. PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice. Welch JS; Yuan W; Ley TJ J Clin Invest; 2011 Apr; 121(4):1636-45. PubMed ID: 21364283 [TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Chim CS; Wong SY; Pang A; Chu P; Lau JS; Wong KF; Kwong YL Leukemia; 2005 Dec; 19(12):2241-6. PubMed ID: 16239915 [TBL] [Abstract][Full Text] [Related]
19. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980 [TBL] [Abstract][Full Text] [Related]
20. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation. Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]